🟢 CervoMed is trading 7.6% up in pre-market with no fresh catalyst identified

CervoMed is trading at $2.41, up 7.59%, in pre-market on October 19, with no fresh company-specific catalyst identified.

• The October 16 close was $2.24.
• CervoMed’s latest identified release, on October 12, reported initial Phase 2a biomarker results.
• Major U.S. indexes were higher, potentially supporting a broader risk-on backdrop, but this does not establish a direct cause for the stock’s move.